Medline Inc. (MDLN)
Stock analysis · NASDAQ · Healthcare · Medical - Instruments & Supplies
Medline Inc. (MDLN) is a publicly traded company in the Healthcare sector. Latest price: $32.12. Market cap $28.18B. Trailing PE 37.35. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.
Get full analysis → Short-Term Analysis →1-Year Price
Earnings
Proprietary Signals
About Medline Inc.
Medline Inc. is a global manufacturer of medical and surgical products, catering to a broad spectrum of healthcare providers. Their clientele includes hospitals, surgical centers, physician practices, post-acute care facilities, and nursing homes, both domestically and worldwide. The company's operations are divided into two primary divisions: the Medline Brand and Supply Chain Solutions. The Medline Brand division focuses on the production and sourcing of its proprietary medical products, categorized into three key areas: Within Frontline Care, Medline provides a wide array of patient-facing medical and surgical items. This encompasses essentials like wound care treatments, examination gloves, skin and incontinence products, sanitation supplies, various textiles, hand sanitizers, durable medical equipment (DME), patient-specific plastic goods, and decolonization and infection control solutions. The Surgical Solutions category delivers comprehensive product lines for operating rooms and perioperative settings. Offerings range from surgical procedure trays, drapes, and gowns to personal protective equipment (PPE), sterile wraps, various surgical instruments, specialized surgeon's g…
Valuation
| P/E (TTM) | 37.35× |
|---|---|
| P/S (TTM) | 0.94× |
| P/B | 2.38× |
| P/FCF (TTM) | 13.91× |
| EV / EBITDA | 14.62× |
| EV / Sales | 1.29× |
| Earnings Yield | 2.51% |
| Free Cash Flow Yield | 7.19% |
Fundamentals
| Enterprise Value | $38.49B |
|---|---|
| Revenue (TTM) | $29.94B |
| Net Income (TTM) | $707.41M |
| Free Cash Flow (TTM) | $2.62B |
| Net Debt | $10.31B |
| Working Capital | $9.03B |
| Gross Margin | 25.02% |
| Operating Margin | 6.07% |
| Net Margin | 2.31% |
| Return on Equity | 5.45% |
| Return on Invested Capital | 4.04% |
Peers
Recent News
- MDLN Stock Market Alert: Medline Under Investigation for Potential Securities Fraud Over Product Quality Issues – Contact BFA Law if You Lo…
- INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Medline Inc. - MDLN
- $MDLN Stock Market Alert: Medline Investigated for Securities Fraud after Product Quality Issues Lead to 13% Stock Drop – Contact BFA Law i…
- INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Medline Inc. - MDLN
- $MDLN Stock Losses: BFA Law Reminds Medline Investors with Losses of the Ongoing Securities Fraud Investigation into Potential Product Qual…
Related
Browse more tickers: sitemap